Skip to main content
. 2021 Mar 9;11:5480. doi: 10.1038/s41598-021-82906-w

Table 2.

Performance characteristic estimates for each index test.

Test Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI) YI (95% CI) Accuracy % (95% CI)
RBT 1:2 85.7 (57.2–98.2) 96.6 (93.1–98.6) 63.2 (38.4–83.7) 99.0 (96.4–99.9) 0.82 (0.81–0.84) 95.9 (92.3–98.1)
RBT 1:8 78.6 (49.2–95.3) 99.0 (96.5–99.9) 84.6 (54.6–98.1) 98.5 (95.8–99.7) 0.78 (0.75–0.80) 97.7 (94.7–99.3)
Amitech 35.7 (12.8–64.9) 69.6 (62.8–75.8) 7.5 (2.5–16.6) 94.0 (89.0–97.2) 0.05 (0.02–0.09) 67.4 (60.8–73.6)
Arkray 64.3 (35.1–87.2) 65.2 (58.2–71.7) 11.3 (5.3–20.3) 96.4 (91.7–98.8) 0.29 (0.26–0.33) 65.1 (58.4–71.4)
Eurocell 50.0 (23.0–77.0) 55.4 (48.3–62.3) 7.1 (2.9–14.2) 94.2 (88.4–97.6) 0.05 (0.02–0.09) 55.0 (48.2–61.8)
Fortress 28.6 (8.4–58.1) 75.0 (68.5–80.8) 7.3 (2.0–17.6) 93.9 (89.0–97.0) 0.04 (0.01–0.07) 72.0 (65.6–77.9)
cELISA 92.9 (66.1–99.8) 89.2 (84.1–93.1) 37.1 (21.5–55.1) 99.5 (97.0–100.0) 0.82 (0.81–0.83) 89.4 (84.6–93.2)

PPV positive predictive value, NPV negative predictive value, YI Youden’s index reported to two decimal places, RBT the Rose Bengal test, cELISA competitive enzyme-linked immunosorbent assay, CI confidence interval.